Literature DB >> 1932242

[Hepatitis C virus infection in different risk groups and among blood donors].

J L Martínez1, J del Hierro, A Camarero, A Medarde, M T López, J Latasa.   

Abstract

We have studied serological markers of viral hepatitis type A, B, delta and C in 7,713 blood-donors, 265 patients with a clinical diagnosis of hepatitis, 41 inmates of a mental and physical retardation institution and 41 health care workers at the same institution and 35 chronic hemodialysis patients. The results showed a 0.8% anti-HCV prevalence in blood-donors, but a higher percentage (47.5%) among HBV positive patients and in two different groups of the inmates at the mental institution (12.5% and 36%). We can not establish a relationship with the presence of anti-HCV and serological markers for HBV or H-delta V, neither with any serological markers pattern of B hepatitis nor with the anti-HCV levels and pathological findings in the biopsy of the cases in which this procedure was performed. The detection of anti-HCV has two direct applications: to exclude positive blood-donors in order to reduce the risk of post-transfusion hepatitis and to better establish a precise diagnosis in patients otherwise classified of having nonA-nonB hepatitis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1932242

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  3 in total

1.  Seroprevalence of hepatitis B and C virus in two institutions caring for mentally handicapped adults.

Authors:  M E Cramp; H C Grundy; R M Perinpanayagam; D E Barnado
Journal:  J R Soc Med       Date:  1996-07       Impact factor: 5.344

2.  Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain.

Authors:  O E Santana Rodríguez; M L Malé Gil; J F HernándezSantana; J M Limiñana Cañal; A M Martín Sánchez
Journal:  Eur J Epidemiol       Date:  1998-09       Impact factor: 8.082

3.  Seroprevalence of hepatitis B and C in a Merseyside hospital for the mentally handicapped.

Authors:  S J Cunningham; R Cunningham; M G Izmeth; B Baker; C A Hart
Journal:  Epidemiol Infect       Date:  1994-02       Impact factor: 2.451

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.